The present invention relates to a dosage form for transmucosal administration comprising a therapeutically effective amount of aliskiren or a pharmaceutically acceptable salt thereof, and an excipient for transmucosal delivery, wherein the active ingredient is present in an amount of 0.001 to 80% by weight based on the total weight of the dosage form.

 
Web www.patentalert.com

< ENHANCEMENT OF DRUG THERAPY BY MIRNA

> Novel nucleic acid sequences encoding adenylate kinases, alcohol dehydrogenases, ubiquitin proteases, lipases, adenylate cyclases, and GTPase activators

> METHODS FOR GENE MAPPING AND HAPLOTYPING

~ 00558